Dapa can improve the ECM stiffness-induced DCM progression and its efficacy on DCM is more pronounced on the soft ECM, which is related to the regulation pathway of AT1R-FAK-NOX2. This evidence concerns the gene AGTR1 and familial dilated cardiomyopathy.